alphaB-crystallin has been found in malignant diseases, such as gliomas, prostate carcinomas, renal cell carcinomas and breast carcinomas[13-15], while its expression has been associated with poor clinical outcome in breast, hepatocellular and head and neck carcinomas[7,11,16,17]. This evidence concerns the gene CRYAB and breast carcinoma.